You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 3
  • 0003: Gemcitabine-Paclitaxel-Carboplatin (TCG) VS. Paclitaxel-Carboplatin (TC) in Ovarian Cancer (OC): A Randomized Phase III Gcig Study (AGOOVAR-9, GINECO-TCG, NSGO-OC-0102)

Citation Tools

Article menu
Download PDFPDF
ABSTRACT: Free Communications: Ovarian Cancer Saturday, October 14, 2006
0003: Gemcitabine-Paclitaxel-Carboplatin (TCG) VS. Paclitaxel-Carboplatin (TC) in Ovarian Cancer (OC): A Randomized Phase III Gcig Study (AGOOVAR-9, GINECO-TCG, NSGO-OC-0102)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Pujade-Lauraine E, Lueck HJ, Bertelsen K, et al
0003: Gemcitabine-Paclitaxel-Carboplatin (TCG) VS. Paclitaxel-Carboplatin (TC) in Ovarian Cancer (OC): A Randomized Phase III Gcig Study (AGOOVAR-9, GINECO-TCG, NSGO-OC-0102)
International Journal of Gynecologic Cancer 2006;16:599.